|

Hydrocortisone Sodium Succinate Clinical Trials

2 actively recruiting trials across 1 location

Also known as: (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium Salt, A-Hydrocort, Buccalsone, Corlan, Cortisol Sodium Succinate +17 more

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Children's Oncology Group1

Indications

  • Cancer2
  • Refractory Juvenile Myelomonocytic Leukemia1
  • Refractory Childhood Myelodysplastic Syndrome1
  • Refractory Childhood Acute Myeloid Leukemia1
  • Recurrent Juvenile Myelomonocytic Leukemia1

Birmingham, Alabama2 trials

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Children's Hospital of Alabama

Phase 2
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Hospital of Alabama

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.